A novel missense mutation, p.Phe360Cys, in FIX gene results in haemophilia B in a female patient with skewed X ‐inactivation
Haemophilia, EarlyView. (Source: Haemophilia)
Source: Haemophilia - February 5, 2018 Category: Hematology Source Type: research
Clinical use of recombinant factor VIII Fc and recombinant factor IX Fc in patients with haemophilia A and B
Haemophilia, EarlyView. (Source: Haemophilia)
Source: Haemophilia - February 5, 2018 Category: Hematology Source Type: research
---
Haemophilia, Ahead of Print. (Source: Haemophilia)
Source: Haemophilia - February 5, 2018 Category: Hematology Source Type: research
Clinical use of recombinant factor VIII Fc and recombinant factor IX Fc in patients with haemophilia A and B
ConclusionThis study demonstrates the largely successful transition of 36 patients from SHL to EHL factor products. (Source: Haemophilia)
Source: Haemophilia - February 5, 2018 Category: Hematology Authors: C. Wang, G. Young Tags: ORIGINAL ARTICLE Source Type: research
High proportion of patients with bleeding of unknown cause in persons with a mild ‐to‐moderate bleeding tendency: Results from the Vienna Bleeding Biobank (VIBB)
Haemophilia, EarlyView. (Source: Haemophilia)
Source: Haemophilia - February 1, 2018 Category: Hematology Source Type: research
World bleeding disorders registry: The pilot study
Haemophilia, EarlyView. (Source: Haemophilia)
Source: Haemophilia - February 1, 2018 Category: Hematology Source Type: research
Successful delivery in an patient with afibrinogenemia after three abortions: A case report and review of the literature
Haemophilia, EarlyView. (Source: Haemophilia)
Source: Haemophilia - February 1, 2018 Category: Hematology Source Type: research
A prospective surveillance study of inhibitor development in haemophilia A patients following a population switch to a third ‐generation B‐domain‐deleted recombinant factor VIII
Haemophilia, EarlyView. (Source: Haemophilia)
Source: Haemophilia - February 1, 2018 Category: Hematology Source Type: research
---
Haemophilia, Ahead of Print. (Source: Haemophilia)
Source: Haemophilia - February 1, 2018 Category: Hematology Source Type: research
In vitro characterization of MOD ‐5014, a novel long‐acting carboxy‐terminal peptide (CTP)‐modified activated FVII
ConclusionThe comparable in vitro activity of MOD‐5014 and rhFVIIa paves the way for in vivo pharmacology evaluations of MOD‐5014 in preparation for clinical studies. (Source: Haemophilia)
Source: Haemophilia - February 1, 2018 Category: Hematology Authors: A. Bar ‐Ilan, T. Livnat, M. Hoffmann, L. Binder, M. Zakar, R. Guy, Y. Felikman, L. Moschcovich, B. Shenkman, D. Monroe, O. Hershkovitz, G. Kenet, G. Hart Tags: ORIGINAL ARTICLE Source Type: research
Management of haemophilia carriers around the time of their delivery: Phenotypic variation requiring customization of management
(Source: Haemophilia)
Source: Haemophilia - February 1, 2018 Category: Hematology Authors: M. R. Girgis, L. Gusba, P. Kuriakose Tags: Letter to the Editor Source Type: research
